1. Genome sequence diversity of SARS-CoV-2 in Serbia: insights gained from a 3-year pandemic study
- Author
-
Mirjana Novkovic, Bojana Banovic Djeri, Bojan Ristivojevic, Aleksandra Knezevic, Marko Jankovic, Vanja Tanasic, Verica Radojicic, Dusan Keckarevic, Dejan Vidanovic, Bojana Tesovic, Anita Skakic, Maja Tolinacki, Ivana Moric, and Valentina Djordjevic
- Subjects
SARS-CoV-2 ,genome ,next generation sequencing ,Serbia ,COVID-19 ,pandemic ,Microbiology ,QR1-502 - Abstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the COVID-19 pandemic, has been evolving rapidly causing emergence of new variants and health uncertainties. Monitoring the evolution of the virus was of the utmost importance for public health interventions and the development of national and global mitigation strategies. Here, we report national data on the emergence of new variants, their distribution, and dynamics in a 3-year study conducted from March 2020 to the end of January 2023 in the Republic of Serbia. Nasopharyngeal and oropharyngeal swabs from 2,398 COVID-19-positive patients were collected and sequenced using three different next generation technologies: Oxford Nanopore, Ion Torrent, and DNBSeq. In the subset of 2,107 SARS-CoV-2 sequences which met the quality requirements, detection of mutations, assignment to SARS-CoV-2 lineages, and phylogenetic analysis were performed. During the 3-year period, we detected three variants of concern, namely, Alpha (5.6%), Delta (7.4%), and Omicron (70.3%) and one variant of interest—Omicron recombinant “Kraken” (XBB1.5) (
- Published
- 2024
- Full Text
- View/download PDF